Home/Filings/4/0001056520-10-000017
4//SEC Filing

LIEBER RANDY 4

Accession 0001056520-10-000017

CIK 0001325279other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:02 PM ET

Size

7.4 KB

Accession

0001056520-10-000017

Insider Transaction Report

Form 4
Period: 2010-01-07
LIEBER RANDY
DirectorPrincipal Accounting Officer
Transactions
  • Award

    Common Stock

    2010-01-07$0.03/sh+500,000$15,5001,664,150 total
  • Award

    Option

    2010-01-13$0.04/sh+4,200,000$147,0008,200,000 total
    Exercise: $0.04From: 2010-01-13Exp: 2015-01-13Common (4,200,000 underlying)
Footnotes (1)
  • [F1]Options shall vest and underlying shares shall become exercisable linearly per month, beginning on the first day of each month. On the first day of each month, so long as Mr. Lieber is a director of the Company, 350,000 options shall become exercisable.

Issuer

CELLCYTE GENETICS CORP

CIK 0001325279

Entity typeother

Related Parties

1
  • filerCIK 0001465074

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:02 PM ET
Size
7.4 KB